Miguel A. Escobar, MD
Professor of Medicine and Pediatrics
Department of Hematology
University of Texas Health Science Center
McGovern Medical School
Gulf States Hemophilia and Thrombophilia Center
Miguel A. Escobar, MD, has disclosed that he has received funds for research support from CSL Behring, Genentech, Novo Nordisk, Sanofi, Takeda, and UniQure (paid to institution) and consulting fees from CSL Behring, BioMarin, Genentech/Roche, HEMA Biologics , Kedrion, NHF, Novo Nordisk, Pfizer, Sanofi, and Takeda.
Mark Reding, MD
Professor of Medicine
Division of Hematology, Oncology and Transplantation
Director, Center for Bleeding and Clotting Disorders
University of Minnesota
Mark Reding, MD, has disclosed that he has received consulting fees from Bayer, CSL Behring, Novo Nordisk, Sanofi Genzyme, and Takeda; funds for research support from Bayer and Biomarin; and fees for non-CME/CE services from Bayer, CSL Behring, Sanofi Genzyme, and Takeda.
Guy A. Young, MD
Professor of Pediatrics
University of Southern California
Keck School of Medicine
Hemostasis and Thrombosis Center
Childrens Hospital Los Angeles
Los Angeles, California
Guy A. Young, MD, has disclosed that he has received funds for research support from Genentech/Roche; fees for non-CME/CE services from Bioverativ, Genentech/Roche, and Sanofi; and consulting fees from CSL-Behring, Genentech/Roche, Grifols, Hema Biologics, Kedrion, Novo Nordisk, Sanofi, Spark, and Takeda.